Szántó, G., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
Pharmaceuticals (Basel). 16 (5), 1-15, 2023.

Cozzolino, M., Gyöngyösi, A., Korpos, É., Gogolák, P., Naseem, M., Kállai, J., Lányi, Á., Panyi, G.: The Voltage-Gated Hv1 H<U+009a> Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells.
Int. J. Mol. Sci. 24 (7), 1-24, 2023.

Erdős, M., Mironska, K., Kareva, L., Stavrik, K., Hasani, A., Lányi, Á., Kállai, J., Maródi, L.: A novel mutation in identified in a patient with autosomal recessive agammaglobulinemia: the impact of the J-Project.
Pediatr. Allergy Immunol. 33 (6), 1-7, 2022.

Erdős, M., Lányi, Á., Balázs, G., Casanova, J., Boisson, B., Maródi, L.: Inherited TOP2B Mutation: possible Confirmation of Mutational Hotspots in the TOPRIM Domain.
J. Clin. Immunol. 41 (4), 817-819, 2021.

Erdős, M., Tsumura, M., Kállai, J., Lányi, Á., Nyúl, Z., Balázs, G., Okada, S., Maródi, L.: Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype.
Clin. Exp. Immunol. 205 (3), 354-362, 2021.

Zagryazhskaya-Masson, A., Monteiro, P., Macé, A., Castagnino, A., Ferrari, R., Infante, E., Duperray-Susini, A., Dingli, F., Lányi, Á., Loew, D., Génot, E., Chavrier, P.: Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.
J. Cell Biol. 219 (9), 1-18, 2020.

Cuenca, M., Sintes, J., Lányi, Á., Engel, P.: CD84 cell surface signaling molecule: an emerging biomarker and target for cancer and autoimmune disorders.
Clin. Immunol. 204 43-49, 2019.

Méhes, E., Baráth, M., Gulyás, M., Bugyik, E., Geiszt, M., Szöőr, Á., Lányi, Á., Czirok, A.: Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
Sci. Rep. 9 (1), 1-13, 2019.

Agod, Z., Pázmándi, K., Bencze, D., Vereb, G., Bíró, T., Szabó, A., Rajnavölgyi, É., Bácsi, A., Engel, P., Lányi, Á.: Signaling Lymphocyte Activation Molecule Family 5 Enhances Autophagy and Fine-Tunes Cytokine Response in Monocyte-Derived Dendritic Cells via Stabilization of Interferon Regulatory Factor 8.
Front. Immunol. 9 1-16, 2018.

Agod, Z., Fekete, T., Budai, M., Varga, A., Szabó, A., Moon, H., Boldogh, I., Bíró, T., Lányi, Á., Bácsi, A., Pázmándi, K.: Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells.
Redox Biol. 13 633-645, 2017.

Szabó, A., Fekete, T., Koncz, G., Kumar, B., Pázmándi, K., Földvári, Z., Hegedűs, B., Garay, T., Bácsi, A., Rajnavölgyi, É., Lányi, Á.: RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1.
Cell. Signal. 28 (5), 335-347, 2016.

Dülk, M., Kudlik, G., Fekete, A., Ernszt, D., Kvell, K., Pongrácz, J., Merő, B., Szeder, B., Radnai, L., Geiszt, M., Csécsy, D., Kovács, T., Uher, F., Lányi, Á., Vas, V., Buday, L.: The scaffold protein Tks4 is required for the differentiation of mesenchymal stromal cells (MSCs) into adipogenic and osteogenic lineages.
Sci Rep. 6 (1), 1-9, 2016.

Pázmándi, K., Agod, Z., Kumar, B., Szabó, A., Fekete, T., Somogyi, V., Veres, Á., Boldogh, I., Rajnavölgyi, É., Lányi, Á., Bácsi, A.: Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA.
Eur. J. Clin. Invest. 45 (2), 65, 2015.

Kovács, I., Horváth, M., Lányi, Á., Petheő, G., Geiszt, M.: Reactive oxygen species-mediated bacterial killing by B lymphocytes.
J. Leukoc. Biol. 97 (6), 1133-1137, 2015.

Lajszné Tóth, B., Soltész, B., Gyimesi, E., Csorba, G., Veres, Á., Lányi, Á., Kovács, G., Maródi, L., Erdős, M.: Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
J. Clin. Immunol. 35 (1), 26-31, 2015.

Lajszné Tóth, B., Soltész, B., Gyimesi, E., Csorba, G., Veres, Á., Lányi, Á., Kovács, G., Erdős, M., Maródi, L.: Molecular Characterization of a Novel Intronic Mutation in the SH2D1A Gene.
J. Clin. Immunol. 34 (Suppl.), S229, 2014.

Pázmándi, K., Agod, Z., Kumar, B., Szabó, A., Fekete, T., Somogyi, V., Veres, Á., Boldogh, I., Rajnavölgyi, É., Lányi, Á., Bácsi, A.: Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells.
Free Radic. Biol. Med. 77 281-290, 2014.

Fekete, T., Szabó, A., Beltrame, L., Vivar, N., Pivarcsi, A., Lányi, Á., Cavalieri, D., Rajnavölgyi, É., Réthi, B.: Constraints for monocyte-derived dendritic cell functions under inflammatory conditions.
Eur. J. Immunol. 42 (2), 458-469, 2012.

Bögel, G., Gujdár, A., Geiszt, M., Lányi, Á., Fekete, A., Sipeki, S., Downward, J., Buday, L.: Frank-ter Haar syndrome protein Tks4 regulates EGF-dependent cell migration.
J. Biol. Chem. 287 (37), 31321-31329, 2012.

Pázmándi, K., Kumar, B., Szabó, K., Boldogh, I., Szöőr, Á., Vereb, G., Veres, Á., Lányi, Á., Rajnavölgyi, É., Bácsi, A.: Ragweed subpollen particles of respirable size activate human dendritic cells.
PLoS One. 7 (12), e52085, 2012.

Pázmándi, K., Kumar, B., Szabó, K., Boldogh, I., Szöőr, Á., Vereb, G., Veres, Á., Lányi, Á., Rajnavölgyi, É., Bácsi, A.: Reactive oxygen species generated by NAD(P)H oxidases in ragweed subpollen particles activate human dendritic cells.
Immunology. 137 458, 2012.

Szabó, A., Bene, K., Gogolák, P., Réthi, B., Lányi, Á., Jankovics, I., Dezső, B., Rajnavölgyi, É.: RLR-mediated production of interferon-beta by a human dendritic cell subset and its role in virus-specific immunity.
J. Leukoc. Biol. 92 (1), 159-169, 2012.

Szabó, A., Osman, R., Bacskai, I., Kumar, B., Agod, Z., Lányi, Á., Gogolák, P., Rajnavölgyi, É.: Temporally designed treatment of melanoma cells by ATRA and polyI:C results in enhanced chemokine and IFNb secretion controlled differently by TLR3 and MDA5.
Melanoma Res. 22 (5), 351-361, 2012.

Altorjay, I., Veréb, Z., Serfőző, Z., Bacskai, I., Bátori, R., Erdődi, F., Udvardy, M., Sipka, S., Lányi, Á., Rajnavölgyi, É., Palatka, K.: Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.
Int. J. Immunopathol. Pharmacol. 24 (2), 323-335, 2011.

Mikó, E., Margitai, Z., Czimmerer, Z., Várkonyi, I., Dezső, B., Lányi, Á., Bacsó, Z., Scholtz, B.: miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
FEBS Lett. 585 (8), 1191-1196, 2011.

Bálint, B., Meskó, B., Nagy, L., Lányi, Á., Scholtz, B., Széles, L., Varga, T.: Molekuláris medicina alapjai.
Debreceni Egyetem, Debrecen, 85 p., 2011.

Lányi, Á., Baráth, M., Péterfi, Z., Bogel, G., Orient, A., Simon, T., Petrovszki, E., Kis-Tóth, K., Sirokmány, G., Rajnavölgyi, É., Terhorst, C., Buday, L., Geiszt, M.: The homolog of the five SH3-domain protein (HOFI/SH3PXD2B) regulates lamellipodia formation and cell spreading.
PLoS One. 6 (8), e23653, 2011.

Töröcsik, D., Baráth, M., Benkő, S., Széles, L., Dezső, B., Póliska, S., Hegyi, Z., Homolya, L., Szatmári, I., Lányi, Á., Nagy, L.: Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli.
J. Immunol. 184 (10), 5456-5464, 2010.

Cavalieri, D., Rivero, D., Beltrame, L., Buschow, S., Calura, E., Rizzetto, L., Gessani, S., Gauzzi, M., Reith, W., Baur, A., Bonaiuti, R., Brandizi, M., De Filippo, C., D'Oro, U., Draghici, S., Dunand-Sauthier, I., Gatti, E., Granucci, F., Gündel, M., Kramer, M., Kuka, M., Lányi, Á., Melief, C., van Montfoort, N., Ostuni, R., Pierre, P., Popovici, R., Rajnavölgyi, É., Schierer, S., Schuler, G., Soumelis, V., Splendiani, A., Stefanini, I., Torcia, M., Zanoni, I., Zollinger, R., Figdor, C., Austyn, J.: DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells.
Immunome Res. 6 (10), 1-12, 2010.

Petheő, G., Orient, A., Baráth, M., Kovács, I., Réthi, B., Lányi, Á., Rajki, A., Rajnavölgyi, É., Geiszt, M.: Molecular and Functional Characterization of H(v)1 Proton Channel in Human Granulocytes.
PloS One. 5 (11), e14081, 2010.

Calpe, S., Wang, N., Romero, X., Berger, S., Lányi, Á., Engel, P., Terhorst, C.: The SLAM and SAP gene families control innate and adaptive immune responses.
Adv. Immunol. 97 177-250, 2008.

Gogolák, P., Réthi, B., Lányi, Á., Dezső, B., Rajnavölgyi, É., Szatmári, I., Nagy, L.: Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma.
Blood. 109 (2), 643-652, 2007.

Calpe, S., Erdős, E., Liao, G., Wang, N., Rietdijk, S., Simarro, M., Scholtz, B., Mooney, J., Lee, C., Shin, M., Rajnavölgyi, É., Schatzle, J., Morse, H., Terhorst, C., Lányi, Á.: Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters.
Immunogenetics. 58 (1), 15-25, 2006.

Réthi, B., Gogolák, P., Szatmári, I., Veres, Á., Erdős, E., Nagy, L., Rajnavölgyi, É., Terhorst, C., Lányi, Á.: SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells.
Blood. 107 (7), 2821-2829, 2006.

Réthi, B., Gogolák, P., Rajnavölgyi, É., Terhorst, C., Lányi, Á.: CD150 (SLAM) modulates TLR and CD40 pathways in monocyte-derived dendritic cells.
Clin. Immunol. 115 (Suppl1), S26-S26, 2005.

Simarro, M., Lányi, Á., Howie, D., Poy, F., Bruggeman, J., Choi, M., Sümegi, J., Eck, M., Terhorst, C.: SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
Trends Immunol. 16 (5), 727-736, 2004.

Chan, B., Lányi, Á., Song, H., Griesbach, J., Simarro-Grande, M., Poy, F., Howie, D., Sümegi, J., Terhorst, C., Eck, M.: SAP couples Fyn to SLAM immune receptors.
Nat. Cell Biol. 5 (2), 155-160, 2003.

Morra, M., Simarro-Grande, M., Martin, M., Chen, A., Lányi, Á., Silander, O., Calpe, S., Davis, J., Pawson, T., Eck, M., Sümegi, J., Engel, P., Li, S., Terhorst, C.: Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients.
J. Biol. Chem. 276 (39), 36809-36816, 2001.

Sümegi, J., Huang, D., Lányi, Á., Davis, J., Seemayer, T., Maeda, A., Klein, G., Seri, M., Wakiguchi, H., Purtilo, D., Gross, T.: Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Blood. 96 (9), 3118-3125, 2000.

Nagy, N., Cerboni, C., Mattsson, K., Maeda, A., Gogolák, P., Sümegi, J., Lányi, Á., Székely, L., Carbone, E., Klein, G., Klein, É.: SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
Int. J. Cancer. 88 (3), 439-447, 2000.